REG - Wells Fargo & Co - Publication of a Prospectus

Wells Fargo & CoAnnouncement

13/04/2022 13:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220413:nRSM3057Ia&default-theme=true

RNS Number : 3057I  Wells Fargo & Company  13 April 2022

Publication of Base Prospectus

 

The following prospectus has been approved by the UK Listing Authority and is
available for viewing:

Base Prospectus dated 7 April 2022 for the Wells Fargo & Company
U.S.$50,000,000,000 Euro Medium Term Note Programme.

To view the full document, please paste the following URL into the address bar
of your browser:

 

http://www.rns-pdf.londonstockexchange.com/rns/3057I_1-2022-4-13.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/3057I_1-2022-4-13.pdf)

 

A copy of this prospectus will be submitted to the National Storage Mechanism
and will shortly be available for inspection
at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

For further information, please contact

John Muller

 +1-704-383-4479 

 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Base Prospectus (the
"Prospectus") may be addressed to and/or targeted at persons who are residents
of particular countries (specified in the Prospectus) only and is not intended
for use and should not be relied upon by any person outside these countries
and/or to whom the offer contained in the Prospectus is not addressed. Prior
to relying on the information contained in the Prospectus you must ascertain
from the Prospectus whether or not you are part of the intended addressees of
the information contained therein.

Your right to access this service is conditional upon complying with the above
requirement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  PDISFFFEDEESEDL